ORBIMED ADVISORS LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is a 10% Owner in CTI BIOPHARMA CORP ($CTIC) and a Director in GLAUKOS Corp ($GKOS) and a Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a in ACCELERON PHARMA INC ($XLRN) and a Director in ProNAi Therapeutics Inc ($DNAI) and a 10% Owner in AVEDRO INC ($AVDR) and a 10% Owner in Relypsa Inc ($RLYP) and a 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and a Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a Director in SELECTA BIOSCIENCES INC ($SELB) and a Director in SI-BONE, Inc. ($SIBN) and a Director in Xtant Medical Holdings, Inc. ($XTNT) and a 10% Owner in Roka BioScience, Inc. ($ROKA) and a Director in Roka BioScience, Inc. ($ROKA) and a 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Otonomy, Inc. ($OTIC) and a 10% Owner in Arsanis, Inc. ($ASNS) and a 10% Owner in Principia Biopharma Inc. ($PRNB) and a Director in Acutus Medical, Inc. ($AFIB) and a Director in SYNLOGIC, INC. ($MIRN) and a 10% Owner in NeuroPace Inc ($NPCE) and a 10% Owner in GRAYBUG VISION, INC. ($GRAY) and a 10% Owner in Sientra, Inc. ($SIEN) and a 10% Owner in TELA Bio, Inc. ($TELA) and a Director in Loxo Oncology, Inc. ($LOXO) and a 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in Dimension Therapeutics, Inc. ($DMTX) and a 10% Owner in Guardant Health, Inc. ($GH) and a 10% Owner in ViewRay, Inc. ($VRAY) and a Director in ViewRay, Inc. ($VRAY) and a Director in Turning Point Therapeutics, Inc. ($TPTX) and a in Tricida, Inc. ($TCDA) and a Director in Tricida, Inc. ($TCDA) and a 10% Owner in Inspire Medical Systems, Inc. ($INSP) and a Director in Inspire Medical Systems, Inc. ($INSP) and a Director in Synthorx, Inc. ($THOR) and a 10% Owner in scPharmaceuticals Inc. ($SCPH) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and a Director in Corvus Pharmaceuticals, Inc. ($CRVS) and a 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and a Director in Audentes Therapeutics, Inc. ($BOLD) and a 10% Owner in SteadyMed Ltd. ($STDY) and a 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a Director in Intellia Therapeutics, Inc. ($NTLA) and a 10% Owner in Alector, Inc. ($ALEC) and a Director in Alector, Inc. ($ALEC) and a Director in Decibel Therapeutics, Inc. ($DBTX) and a Director in NextCure, Inc. ($NXTC) and a Director in LogicBio Therapeutics, Inc. ($LOGC) and a Director in Silverback Therapeutics, Inc. ($SBTX) and a Director in IMARA Inc. ($IMRA) and a Director in Keros Therapeutics, Inc. ($KROS) and a Director in Prelude Therapeutics Inc ($PRLD) and a Director in PMV Pharmaceuticals, Inc. ($PMVP) and a Director in ARMO BioSciences, Inc. ($ARMO) and a Director in resTORbio, Inc. ($TORC) and a Director in Prevail Therapeutics Inc. ($PRVL) and a 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and a Director in Edgewise Therapeutics, Inc. ($EWTX) and a Director in 89bio, Inc. ($ETNB) and a Director in Arcutis Biotherapeutics, Inc. ($ARQT) and a in Kinnate Biopharma Inc. ($KNTE) and a Director in Oric Pharmaceuticals, Inc. ($ORIC) and a Director in Repare Therapeutics Inc. ($RPTX) and a Director in Fusion Pharmaceuticals Inc. ($FUSN) and a Director in Terns Pharmaceuticals, Inc. ($TERN) and a Director in Ikena Oncology, Inc. ($IKNA).
Companies in which ORBIMED ADVISORS LLC is an Insider
89bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,864,721 shares
Latest Transaction: Sep 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC:
Holdings: 576,889 shares
Current Value: $13,695,345
Latest Transaction: Sep 26 2013
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Acutus Medical, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 373,500 shares
Latest Transaction: Aug 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,902,910 shares
Current Value: $22,210,182
Latest Transaction: Jun 06 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adicet Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 5,243,259 shares
Latest Transaction: Feb 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aeglea BioTherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,390,724 shares
Current Value: $5,827,134
Latest Transaction: Feb 21 2017
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aerpio Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 21,400 shares
Latest Transaction: Dec 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Alector, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 6,002,771 shares
Latest Transaction: Apr 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,070,955 shares
Current Value: $7,186,035
Latest Transaction: Dec 30 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcutis Biotherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,267,564 shares
Latest Transaction: Oct 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARMO BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,709,356 shares
Latest Transaction: Jun 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 3,638,000 shares
Current Value: $57,589,540
Latest Transaction: Mar 12 2018
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVEDRO INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,523,204 shares
Latest Transaction: Feb 19 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONSTELLATION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 317,921 shares
Latest Transaction: Jul 24 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Corvus Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 8,053,298 shares
Current Value: $111,377,111
Latest Transaction: Feb 19 2021
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CTI BIOPHARMA CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 7,520,600 shares
Current Value: $35,121,202
Latest Transaction: Jan 11 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Decibel Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,732,106 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dimension Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 5,397,698 shares
Current Value: $8,906,202
Latest Transaction: Oct 29 2015
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Edgewise Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 13,046,956 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Fusion Pharmaceuticals Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,224,770 shares
Latest Transaction: Jul 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GLAUKOS Corp
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 562,839 shares
Current Value: $24,950,653
Latest Transaction: Mar 06 2018
$GKOS Market Capitalization: $1.51B
$GKOS Previous Close: $44.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GRAYBUG VISION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 562,500 shares
Latest Transaction: Sep 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Guardant Health, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,525,492 shares
Latest Transaction: Oct 11 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ikena Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,816,425 shares
Latest Transaction: Apr 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMARA Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 937,500 shares
Latest Transaction: Mar 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inspire Medical Systems, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director, 10% Owner
Holdings: 43,543 shares
Latest Transaction: Aug 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,662,180 shares
Current Value: $35,406,994
Latest Transaction: May 13 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,120,609 shares
Current Value: $127,267,564
Latest Transaction: Jul 21 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kala Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,422,840 shares
Latest Transaction: Feb 06 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Keros Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 744,612 shares
Latest Transaction: Apr 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kinnate Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC:
Holdings: 543,494 shares
Latest Transaction: Dec 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LogicBio Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,524,997 shares
Latest Transaction: Oct 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 941,000 shares
Current Value: $37,357,700
Latest Transaction: Dec 12 2017
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeuroPace Inc
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 4,012,281 shares
Latest Transaction: Apr 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NextCure, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 445,866 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oric Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,240,440 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OTONOMY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,850,094 shares
Current Value: $26,826,363
Latest Transaction: Nov 30 2015
$OTIC Market Capitalization: $442.34M
$OTIC Previous Close: $14.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PIERIS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 4,511,130 shares
Current Value: $9,924,486
Latest Transaction: May 02 2018
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PMV Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 475,000 shares
Latest Transaction: Sep 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prelude Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 526,300 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Principia Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,605,713 shares
Latest Transaction: May 22 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,700,000 shares
Latest Transaction: Jul 26 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Repare Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,601,325 shares
Latest Transaction: Jun 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RESPONSE BIOMEDICAL CORP
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: Dec 01 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 2,751,679 shares
Latest Transaction: May 24 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
scPharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 4,565,948 shares
Latest Transaction: May 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELECTA BIOSCIENCES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 12,193 shares
Latest Transaction: Jun 29 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SI-BONE, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 605,964 shares
Latest Transaction: Oct 19 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sientra, Inc.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 17,100 shares
Current Value: $143,811
Latest Transaction: Oct 13 2015
$SIEN Market Capitalization: $156.38M
$SIEN Previous Close: $8.41
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,477,320 shares
Latest Transaction: Jan 31 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Silverback Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 507,423 shares
Latest Transaction: Dec 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sorrento Tech, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SpringWorks Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 6,078,103 shares
Latest Transaction: Sep 19 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SteadyMed Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 07 2018
$STDY Market Capitalization: $68.47M
$STDY Previous Close: $3.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,696,662 shares
Current Value: $8,132,656
Latest Transaction: Apr 22 2021
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Synthorx, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,363,636 shares
Latest Transaction: Dec 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TELA Bio, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,568,627 shares
Latest Transaction: Nov 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Terns Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,326,481 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tricida, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 9,614,280 shares
Latest Transaction: Dec 12 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Turning Point Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,120,730 shares
Latest Transaction: Apr 24 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ViewRay, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 7,464,378 shares
Current Value: $44,413,049
Latest Transaction: Aug 20 2018
$VRAY Market Capitalization: $257.35M
$VRAY Previous Close: $5.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
X4 Pharmaceuticals, Inc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 19,533 shares
Latest Transaction: Nov 20 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xtant Medical Holdings, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 53,468,376 shares
Current Value: $24,060,769
Latest Transaction: Nov 19 2020
$XTNT Market Capitalization: $5.29M
$XTNT Previous Close: $0.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,605,386 | 0 | 0 | |
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 171,895 | 0 | 0 | |
| Apr 26 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,777,281 | 0 | 4,012,281 | 235 K to 4 M (+1,607.35 %) |
| Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
| Apr 23 2021 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 235,000 | 0 to 235 K |
| Apr 22 2021 | SYBX | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Grant | A | 3.00 | 1,666,666 | 4,999,998 | 3,696,662 | 2 M to 3.7 M (+82.10 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 |